IL1B and disease of the tendon: As inflammation is an underlying mechanism of tendinopathy pathogenesis [23], mitochondrial transfer suppressed the levels of pro-inflammatory markers (IL-1β, IL-6, and TNF-α), revealing a promising therapeutic strategy against inflammatory.